===================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 4, 2004
PETMED EXPRESS, INC.
----------------------------------------------------
(Exact name of registrant as specified in its charter)
Commission file number 000-28827
FLORIDA 65-0680967
--------------------------- ---------------
(State or other jurisdiction (IRS Employer
of incorporation or organization) Identification No.)
1441 S.W. 29th Avenue, Pompano Beach, Florida 33069
--------------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (954) 979-5995
--------------
Not Applicable
-----------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
[ ] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act
[ ] Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act
Item 7.01 Regulation FD Disclosure
------------------------
On November 4, 2004, PetMed Express, Inc. issued a press
release announcing a new marketing agreement. A copy of this news
release is attached hereto as Exhibit 99.1 and is incorporated
herein by reference.
The information furnished in this Item 9, intended to be
furnished under Item 12, is instead furnished under Item 9 in
accordance with SEC Release 33-8216. This information shall not
be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") nor shall
such information be incorporated by reference in any filing
under the Securities Act of 1933, as amended, or the Exchange
Act, except as shall be expressly set forth by specific
reference in such filing.
Item 9.01 Financial Statements and Exhibits
---------------------------------
(c) Exhibits
--------
99.1 Press Release issued by PetMed Express, Inc. on November 4, 2004
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
PETMED EXPRESS, INC.
(The "Registrant")
Date: November 5, 2004
By: /s/ Menderes Akdag
-----------------------
Menderes Akdag
Chief Executive Officer
(principal executive officer)
By: /s/ Bruce S. Rosenbloom
---------------------------
Bruce S. Rosenbloom
Chief Financial Officer
(principal financial and accounting officer)
EXHIBIT INDEX
Exhibit No. Description
99.1 Press Release issued by PetMed Express on November 4, 2004